GRP and small cell lung carcinoma: A study from 2023 from China reported that ProGRP levels in patients with SCLC were higher than in the healthy control group (p < 0.05) and in the benign lung disease group (p < 0.05); the sensitivity and specificity of ProGRP was estimated at 77.45% and 86.67%, respectively [38].